MTEM - スレッシュ・ホ―ルド・ファ―マス―ティカルズ (Molecular Templates Inc.)

MTEMのニュース

   BRIEF-Molecular Templates Inc Announces $45 Mln Debt Financing From K2 Healthventures  2020/05/22 12:49:30 Reuters
Molecular Templates Inc:
   DZ Bank likes Medtronic in premarket analyst action  2020/03/25 11:14:36 Seeking Alpha
Menlo Therapeutics (NASDAQ:MNLO) initiated with Overweight rating and $8 (161% upside) price target at Barclays. Molecular Templates (NASDAQ:MTEM) initiate
   The Daily Biotech Pulse: Breakthrough Device Designation For Neuronetics, AbbVie Receives European Label Expansion, AstraZeneca Flunks Late-Stage Study  2020/03/06 13:49:43 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit hit 52-week highs March 5.) Arcus Biosciences Inc (NYSE: RCUS ) Arcturus Therapeutics Ltd (NASDAQ: ARCT ) BioMarin Pharmaceutical Inc. (NASDAQ: BMRN ) Centogene NV (NASDAQ: CNTG ) Cue Biopharma Inc (NASDAQ: CUE ) Forty Seven Inc (NASDAQ: FTSV ) Inovio Pharmaceuticals Inc (NASDAQ: INO ) Molecular Templates Inc (NASDAQ: MTEM ) Natera Inc (NASDAQ: NTRA ) Ocular Therapeutix Inc (NASDAQ: OCUL ) (Piper Sandler lifted the price target for the shares from $7 to $11) Quest Diagnostics Inc (NYSE: DGX ) (announced plans to launch a COVID-19 test service) Regeneron Pharmaceuticals Inc (NASDAQ: REGN ) Syndax Pharmaceuticals Inc (NASDAQ: SNDX ) Zynex Inc. (NASDAQ: ZYXI ) Down In The Dumps (Biotech stocks that hit 52-week lows March 5.) Aldeyra Therapeutics Inc (NASDAQ: ALDX ) AngioDynamics, Inc. (NASDAQ: ANGO ) ANI Pharmaceuticals Inc Common Stock (NASDAQ: ANIP ) Aytu Bioscience Inc (NASDAQ: AYTU ) Celcuity Inc (NASDAQ: CELC ) Chembio Diagnostics Inc (NASDAQ: CEMI ) Eagle Pharmaceuticals Inc (NASDAQ: EGRX ) Eiger Biopharmaceuticals Inc (NASDAQ: EIGR ) Enlivex Therapeutics Ltd (NASDAQ: ENLV ) Evogene Ltd (NASDAQ: EVGN ) EXACT Sciences Corporation (NASDAQ: EXAS ) Glaukos Corp (NYSE: GKOS ) Lantheus Holdings Inc (NASDAQ: LNTH ) Mylan NV (NASDAQ: MYL ) Neurometrix Inc (NASDAQ: NURO ) Organogenesis Holdings Inc (NASDAQ: ORGO ) Orthofix Medical Inc (NASDAQ: OFIX ) Passage Bio Inc (NASDAQ: PASG ) (went public last week) Polarityte Inc (NASDAQ: PTE ) STRATA Skin Sciences Inc (NASDAQ: SSKN ) SurModics, Inc. (NASDAQ: SRDX ) (reacted to first-quarter results) T2 Biosystems Inc (NASDAQ: TTOO ) Xeris …
   MTEM urges new govt to intensify Bumiputera empowerment agenda  2020/03/04 03:25:38 The Sun Daily
KUALA LUMPUR : The Malay Economic Action Council (MTEM) wants Shared Prosperity Vision 2030 (SPV2030), which will be continued under the new government led by Prime Minister Tan Sri Muhyiddin Yassin, to address economic disparities between the races and create a high-value economy. Chief executive officer Ahmad Yazid Othman said the Bumiputera economic community is hoping that the Bumiputera empowerment agenda will be stepped up under the new administration. “Several Bumiputera achievement targets need to be reviewed, and the government should implement quickly development projects to mobilise the economy based on a Bumiputera master policy under SPV2030, instead of continuing the austerity drive which is only to demonstrate political messages but does not benefit the country and the people. “Do not let the market forces philosophy to dictate the country’s fate. We have to accept the need for state intervention so that the quality of life of all Malaysians, especially Bumiputeras, can be improved swiftly,” he said in a statement tonight.
   The Daily Biotech Pulse: Tonix Slumps On Failed Study, Applied Genetic Announces Offering, Beam Therapeutics, PPD Price IPOs  2020/02/06 12:47:50 Benzinga
The following is a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs Feb. 5.) Alector Inc (NASDAQ: ALEC ) (announced granting of Fast Track Designation to its AL101 for the treatment of patients with frontotemporal dementia) Arvinas Inc (NASDAQ: ARVN ) Ascendis Pharma A/S (NASDAQ: ASND ) Biogen Inc (NASDAQ: BIIB ) (won patent challenge on multiple sclerosis drug Tecfidera) BioXcel Therapeutics Inc (NASDAQ: BTAI ) (announced FDA clearance of IND for BXCL501 to treat opioid withdrawal symptoms) ChemoCentryx Inc (NASDAQ: CCXI ) Eli Lilly And Co (NYSE: LLY ) Insmed Incorporated (NASDAQ: INSM ) Halozyme Therapeutics, Inc. (NASDAQ: HALO ) Insulet Corporation (NASDAQ: PODD ) Johnson & Johnson (NYSE: JNJ ) Masimo Corporation (NASDAQ: MASI ) Medpace Holdings Inc (NASDAQ: MEDP ) Molecular Templates Inc (NASDAQ: MTEM ) Novo Nordisk A/S (NYSE: NVO ) (reacted to quarterly results ) Profound Medical Corp (NASDAQ: PROF ) (announced retirement of bank debt ahead of schedule) PTC Therapeutics, Inc (NASDAQ: PTCT ) Quest Diagnostics Inc (NYSE: DGX ) Reata Pharmaceuticals Inc (NASDAQ: RETA ) Repligen Corporation (NASDAQ: RGEN ) ResMed Inc. (NYSE: RMD ) Revance Therapeutics Inc (NASDAQ: RVNC ) Theravance Biopharma Inc (NASDAQ: TBPH ) Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX ) ZEALAND PHARMA/S ADR (NASDAQ: ZEAL ) Down In The Dumps (Biotech stocks that hit 52-week lows Feb. 5.) Endologix, Inc. (NASDAQ: ELGX ) Salarius Pharmaceuticals Inc (NASDAQ: SLRX ) Spring Bank Pharmaceuticals Inc (NASDAQ: SBPH ) See also: The Week Ahead In Biotech: Merck, Bristol-Myers Earnings, Conference Presentations In Focus Stocks In Focus Sanofi's Multiple Sclerosis Drug Aces Midstage Trial; Q4 Sales, Net Income Rise Sanofi SA (NASDAQ: SNY ) said a Phase 2b study that evaluated its investigational BTK inhibitor SAR442168 for multiple sclerosis met the primary endpoint, …
   BRIEF-Molecular Templates Inc Announces $45 Mln Debt Financing From K2 Healthventures  2020/05/22 12:49:30 Reuters
Molecular Templates Inc:
   DZ Bank likes Medtronic in premarket analyst action  2020/03/25 11:14:36 Seeking Alpha
Menlo Therapeutics (NASDAQ:MNLO) initiated with Overweight rating and $8 (161% upside) price target at Barclays. Molecular Templates (NASDAQ:MTEM) initiate
   The Daily Biotech Pulse: Breakthrough Device Designation For Neuronetics, AbbVie Receives European Label Expansion, AstraZeneca Flunks Late-Stage Study  2020/03/06 13:49:43 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit hit 52-week highs March 5.) Arcus Biosciences Inc (NYSE: RCUS ) Arcturus Therapeutics Ltd (NASDAQ: ARCT ) BioMarin Pharmaceutical Inc. (NASDAQ: BMRN ) Centogene NV (NASDAQ: CNTG ) Cue Biopharma Inc (NASDAQ: CUE ) Forty Seven Inc (NASDAQ: FTSV ) Inovio Pharmaceuticals Inc (NASDAQ: INO ) Molecular Templates Inc (NASDAQ: MTEM ) Natera Inc (NASDAQ: NTRA ) Ocular Therapeutix Inc (NASDAQ: OCUL ) (Piper Sandler lifted the price target for the shares from $7 to $11) Quest Diagnostics Inc (NYSE: DGX ) (announced plans to launch a COVID-19 test service) Regeneron Pharmaceuticals Inc (NASDAQ: REGN ) Syndax Pharmaceuticals Inc (NASDAQ: SNDX ) Zynex Inc. (NASDAQ: ZYXI ) Down In The Dumps (Biotech stocks that hit 52-week lows March 5.) Aldeyra Therapeutics Inc (NASDAQ: ALDX ) AngioDynamics, Inc. (NASDAQ: ANGO ) ANI Pharmaceuticals Inc Common Stock (NASDAQ: ANIP ) Aytu Bioscience Inc (NASDAQ: AYTU ) Celcuity Inc (NASDAQ: CELC ) Chembio Diagnostics Inc (NASDAQ: CEMI ) Eagle Pharmaceuticals Inc (NASDAQ: EGRX ) Eiger Biopharmaceuticals Inc (NASDAQ: EIGR ) Enlivex Therapeutics Ltd (NASDAQ: ENLV ) Evogene Ltd (NASDAQ: EVGN ) EXACT Sciences Corporation (NASDAQ: EXAS ) Glaukos Corp (NYSE: GKOS ) Lantheus Holdings Inc (NASDAQ: LNTH ) Mylan NV (NASDAQ: MYL ) Neurometrix Inc (NASDAQ: NURO ) Organogenesis Holdings Inc (NASDAQ: ORGO ) Orthofix Medical Inc (NASDAQ: OFIX ) Passage Bio Inc (NASDAQ: PASG ) (went public last week) Polarityte Inc (NASDAQ: PTE ) STRATA Skin Sciences Inc (NASDAQ: SSKN ) SurModics, Inc. (NASDAQ: SRDX ) (reacted to first-quarter results) T2 Biosystems Inc (NASDAQ: TTOO ) Xeris …
   MTEM urges new govt to intensify Bumiputera empowerment agenda  2020/03/04 03:25:38 The Sun Daily
KUALA LUMPUR : The Malay Economic Action Council (MTEM) wants Shared Prosperity Vision 2030 (SPV2030), which will be continued under the new government led by Prime Minister Tan Sri Muhyiddin Yassin, to address economic disparities between the races and create a high-value economy. Chief executive officer Ahmad Yazid Othman said the Bumiputera economic community is hoping that the Bumiputera empowerment agenda will be stepped up under the new administration. “Several Bumiputera achievement targets need to be reviewed, and the government should implement quickly development projects to mobilise the economy based on a Bumiputera master policy under SPV2030, instead of continuing the austerity drive which is only to demonstrate political messages but does not benefit the country and the people. “Do not let the market forces philosophy to dictate the country’s fate. We have to accept the need for state intervention so that the quality of life of all Malaysians, especially Bumiputeras, can be improved swiftly,” he said in a statement tonight.
   The Daily Biotech Pulse: Tonix Slumps On Failed Study, Applied Genetic Announces Offering, Beam Therapeutics, PPD Price IPOs  2020/02/06 12:47:50 Benzinga
The following is a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs Feb. 5.) Alector Inc (NASDAQ: ALEC ) (announced granting of Fast Track Designation to its AL101 for the treatment of patients with frontotemporal dementia) Arvinas Inc (NASDAQ: ARVN ) Ascendis Pharma A/S (NASDAQ: ASND ) Biogen Inc (NASDAQ: BIIB ) (won patent challenge on multiple sclerosis drug Tecfidera) BioXcel Therapeutics Inc (NASDAQ: BTAI ) (announced FDA clearance of IND for BXCL501 to treat opioid withdrawal symptoms) ChemoCentryx Inc (NASDAQ: CCXI ) Eli Lilly And Co (NYSE: LLY ) Insmed Incorporated (NASDAQ: INSM ) Halozyme Therapeutics, Inc. (NASDAQ: HALO ) Insulet Corporation (NASDAQ: PODD ) Johnson & Johnson (NYSE: JNJ ) Masimo Corporation (NASDAQ: MASI ) Medpace Holdings Inc (NASDAQ: MEDP ) Molecular Templates Inc (NASDAQ: MTEM ) Novo Nordisk A/S (NYSE: NVO ) (reacted to quarterly results ) Profound Medical Corp (NASDAQ: PROF ) (announced retirement of bank debt ahead of schedule) PTC Therapeutics, Inc (NASDAQ: PTCT ) Quest Diagnostics Inc (NYSE: DGX ) Reata Pharmaceuticals Inc (NASDAQ: RETA ) Repligen Corporation (NASDAQ: RGEN ) ResMed Inc. (NYSE: RMD ) Revance Therapeutics Inc (NASDAQ: RVNC ) Theravance Biopharma Inc (NASDAQ: TBPH ) Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX ) ZEALAND PHARMA/S ADR (NASDAQ: ZEAL ) Down In The Dumps (Biotech stocks that hit 52-week lows Feb. 5.) Endologix, Inc. (NASDAQ: ELGX ) Salarius Pharmaceuticals Inc (NASDAQ: SLRX ) Spring Bank Pharmaceuticals Inc (NASDAQ: SBPH ) See also: The Week Ahead In Biotech: Merck, Bristol-Myers Earnings, Conference Presentations In Focus Stocks In Focus Sanofi's Multiple Sclerosis Drug Aces Midstage Trial; Q4 Sales, Net Income Rise Sanofi SA (NASDAQ: SNY ) said a Phase 2b study that evaluated its investigational BTK inhibitor SAR442168 for multiple sclerosis met the primary endpoint, …
   BRIEF-Molecular Templates Inc Announces $45 Mln Debt Financing From K2 Healthventures  2020/05/22 12:49:30 Reuters
Molecular Templates Inc:
   DZ Bank likes Medtronic in premarket analyst action  2020/03/25 11:14:36 Seeking Alpha
Menlo Therapeutics (NASDAQ:MNLO) initiated with Overweight rating and $8 (161% upside) price target at Barclays. Molecular Templates (NASDAQ:MTEM) initiate
   The Daily Biotech Pulse: Breakthrough Device Designation For Neuronetics, AbbVie Receives European Label Expansion, AstraZeneca Flunks Late-Stage Study  2020/03/06 13:49:43 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit hit 52-week highs March 5.) Arcus Biosciences Inc (NYSE: RCUS ) Arcturus Therapeutics Ltd (NASDAQ: ARCT ) BioMarin Pharmaceutical Inc. (NASDAQ: BMRN ) Centogene NV (NASDAQ: CNTG ) Cue Biopharma Inc (NASDAQ: CUE ) Forty Seven Inc (NASDAQ: FTSV ) Inovio Pharmaceuticals Inc (NASDAQ: INO ) Molecular Templates Inc (NASDAQ: MTEM ) Natera Inc (NASDAQ: NTRA ) Ocular Therapeutix Inc (NASDAQ: OCUL ) (Piper Sandler lifted the price target for the shares from $7 to $11) Quest Diagnostics Inc (NYSE: DGX ) (announced plans to launch a COVID-19 test service) Regeneron Pharmaceuticals Inc (NASDAQ: REGN ) Syndax Pharmaceuticals Inc (NASDAQ: SNDX ) Zynex Inc. (NASDAQ: ZYXI ) Down In The Dumps (Biotech stocks that hit 52-week lows March 5.) Aldeyra Therapeutics Inc (NASDAQ: ALDX ) AngioDynamics, Inc. (NASDAQ: ANGO ) ANI Pharmaceuticals Inc Common Stock (NASDAQ: ANIP ) Aytu Bioscience Inc (NASDAQ: AYTU ) Celcuity Inc (NASDAQ: CELC ) Chembio Diagnostics Inc (NASDAQ: CEMI ) Eagle Pharmaceuticals Inc (NASDAQ: EGRX ) Eiger Biopharmaceuticals Inc (NASDAQ: EIGR ) Enlivex Therapeutics Ltd (NASDAQ: ENLV ) Evogene Ltd (NASDAQ: EVGN ) EXACT Sciences Corporation (NASDAQ: EXAS ) Glaukos Corp (NYSE: GKOS ) Lantheus Holdings Inc (NASDAQ: LNTH ) Mylan NV (NASDAQ: MYL ) Neurometrix Inc (NASDAQ: NURO ) Organogenesis Holdings Inc (NASDAQ: ORGO ) Orthofix Medical Inc (NASDAQ: OFIX ) Passage Bio Inc (NASDAQ: PASG ) (went public last week) Polarityte Inc (NASDAQ: PTE ) STRATA Skin Sciences Inc (NASDAQ: SSKN ) SurModics, Inc. (NASDAQ: SRDX ) (reacted to first-quarter results) T2 Biosystems Inc (NASDAQ: TTOO ) Xeris …
   MTEM urges new govt to intensify Bumiputera empowerment agenda  2020/03/04 03:25:38 The Sun Daily
KUALA LUMPUR : The Malay Economic Action Council (MTEM) wants Shared Prosperity Vision 2030 (SPV2030), which will be continued under the new government led by Prime Minister Tan Sri Muhyiddin Yassin, to address economic disparities between the races and create a high-value economy. Chief executive officer Ahmad Yazid Othman said the Bumiputera economic community is hoping that the Bumiputera empowerment agenda will be stepped up under the new administration. “Several Bumiputera achievement targets need to be reviewed, and the government should implement quickly development projects to mobilise the economy based on a Bumiputera master policy under SPV2030, instead of continuing the austerity drive which is only to demonstrate political messages but does not benefit the country and the people. “Do not let the market forces philosophy to dictate the country’s fate. We have to accept the need for state intervention so that the quality of life of all Malaysians, especially Bumiputeras, can be improved swiftly,” he said in a statement tonight.
   The Daily Biotech Pulse: Tonix Slumps On Failed Study, Applied Genetic Announces Offering, Beam Therapeutics, PPD Price IPOs  2020/02/06 12:47:50 Benzinga
The following is a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs Feb. 5.) Alector Inc (NASDAQ: ALEC ) (announced granting of Fast Track Designation to its AL101 for the treatment of patients with frontotemporal dementia) Arvinas Inc (NASDAQ: ARVN ) Ascendis Pharma A/S (NASDAQ: ASND ) Biogen Inc (NASDAQ: BIIB ) (won patent challenge on multiple sclerosis drug Tecfidera) BioXcel Therapeutics Inc (NASDAQ: BTAI ) (announced FDA clearance of IND for BXCL501 to treat opioid withdrawal symptoms) ChemoCentryx Inc (NASDAQ: CCXI ) Eli Lilly And Co (NYSE: LLY ) Insmed Incorporated (NASDAQ: INSM ) Halozyme Therapeutics, Inc. (NASDAQ: HALO ) Insulet Corporation (NASDAQ: PODD ) Johnson & Johnson (NYSE: JNJ ) Masimo Corporation (NASDAQ: MASI ) Medpace Holdings Inc (NASDAQ: MEDP ) Molecular Templates Inc (NASDAQ: MTEM ) Novo Nordisk A/S (NYSE: NVO ) (reacted to quarterly results ) Profound Medical Corp (NASDAQ: PROF ) (announced retirement of bank debt ahead of schedule) PTC Therapeutics, Inc (NASDAQ: PTCT ) Quest Diagnostics Inc (NYSE: DGX ) Reata Pharmaceuticals Inc (NASDAQ: RETA ) Repligen Corporation (NASDAQ: RGEN ) ResMed Inc. (NYSE: RMD ) Revance Therapeutics Inc (NASDAQ: RVNC ) Theravance Biopharma Inc (NASDAQ: TBPH ) Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX ) ZEALAND PHARMA/S ADR (NASDAQ: ZEAL ) Down In The Dumps (Biotech stocks that hit 52-week lows Feb. 5.) Endologix, Inc. (NASDAQ: ELGX ) Salarius Pharmaceuticals Inc (NASDAQ: SLRX ) Spring Bank Pharmaceuticals Inc (NASDAQ: SBPH ) See also: The Week Ahead In Biotech: Merck, Bristol-Myers Earnings, Conference Presentations In Focus Stocks In Focus Sanofi's Multiple Sclerosis Drug Aces Midstage Trial; Q4 Sales, Net Income Rise Sanofi SA (NASDAQ: SNY ) said a Phase 2b study that evaluated its investigational BTK inhibitor SAR442168 for multiple sclerosis met the primary endpoint, …

calendar